170 related articles for article (PubMed ID: 27609636)
1. Acanthamoeba castellanii: A new high-throughput method for drug screening in vitro.
Ortega-Rivas A; Padrón JM; Valladares B; Elsheikha HM
Acta Trop; 2016 Dec; 164():95-99. PubMed ID: 27609636
[TBL] [Abstract][Full Text] [Related]
2. Development of colorimetric microtiter plate assay for assessment of antimicrobials against Acanthamoeba.
McBride J; Ingram PR; Henriquez FL; Roberts CW
J Clin Microbiol; 2005 Feb; 43(2):629-34. PubMed ID: 15695656
[TBL] [Abstract][Full Text] [Related]
3. In vitro comparative assessment of different viability assays in Acanthamoeba castellanii and Acanthamoeba polyphaga trophozoites.
Heredero-Bermejo I; Copa-Patiño JL; Soliveri J; Gómez R; de la Mata FJ; Pérez-Serrano J
Parasitol Res; 2013 Dec; 112(12):4087-95. PubMed ID: 24026387
[TBL] [Abstract][Full Text] [Related]
4. Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles.
Anwar A; Yi YP; Fatima I; Khan KM; Siddiqui R; Khan NA; Anwar A
Parasitol Res; 2020 Jun; 119(6):1943-1954. PubMed ID: 32385711
[TBL] [Abstract][Full Text] [Related]
5. Effect of povidone iodine, chlorhexidine digluconate and toyocamycin on amphizoic amoebic strains, infectious agents of
Padzik M; Baltaza W; Conn DB; Szaflik JP; Chomicz L
Ann Agric Environ Med; 2018 Dec; 25(4):725-731. PubMed ID: 30586959
[TBL] [Abstract][Full Text] [Related]
6. Acanthamoeba castellanii Neff: In vitro activity against the trophozoite stage of a natural sesquiterpene and a synthetic cobalt(II)-lapachol complex.
Martín-Navarro CM; López-Arencibia A; Lorenzo-Morales J; Oramas-Royo S; Hernández-Molina R; Estévez-Braun A; Ravelo AG; Valladares B; Piñero JE
Exp Parasitol; 2010 Sep; 126(1):106-8. PubMed ID: 20045692
[TBL] [Abstract][Full Text] [Related]
7. Effect of non-steroidal anti-inflammatory drugs on biological properties of Acanthamoeba castellanii belonging to the T4 genotype.
Siddiqui R; Lakhundi S; Iqbal J; Khan NA
Exp Parasitol; 2016 Sep; 168():45-50. PubMed ID: 27381503
[TBL] [Abstract][Full Text] [Related]
8. The effect of peptidic and non-peptidic proteasome inhibitors on the biological properties of Acanthamoeba castellanii belonging to the T4 genotype.
Siddiqui R; Saleem S; Khan NA
Exp Parasitol; 2016 Sep; 168():16-24. PubMed ID: 27327524
[TBL] [Abstract][Full Text] [Related]
9. PrestoBlue® and AlamarBlue® are equally useful as agents to determine the viability of Acanthamoeba trophozoites.
Martín-Navarro CM; López-Arencibia A; Sifaoui I; Reyes-Batlle M; Cabello-Vílchez AM; Maciver S; Valladares B; Piñero JE; Lorenzo-Morales J
Exp Parasitol; 2014 Nov; 145 Suppl():S69-72. PubMed ID: 24703973
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.
Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Vanzzini-Zago V; Ramírez-Flores E; Sifaoui I; Piñero JE; Lorenzo-Morales J; Omaña-Molina M
Exp Parasitol; 2019 Feb; 197():29-35. PubMed ID: 30648558
[TBL] [Abstract][Full Text] [Related]
11. Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages.
Anwar A; Soomaroo A; Anwar A; Siddiqui R; Khan NA
Exp Parasitol; 2020 Aug; 215():107915. PubMed ID: 32461112
[TBL] [Abstract][Full Text] [Related]
12. In vitro efficacies of clinically available drugs against growth and viability of an Acanthamoeba castellanii keratitis isolate belonging to the T4 genotype.
Baig AM; Iqbal J; Khan NA
Antimicrob Agents Chemother; 2013 Aug; 57(8):3561-7. PubMed ID: 23669391
[TBL] [Abstract][Full Text] [Related]
13. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
Mrva M; Garajová M; Lukáč M; Ondriska F
J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
[TBL] [Abstract][Full Text] [Related]
14. Lethal effects of Helianthemum lippii (L.) on Acanthamoeba castellanii cysts in vitro.
Badria FA; Hetta MH; Sarhan RM; Ezz El-Din MH
Korean J Parasitol; 2014 Jun; 52(3):243-9. PubMed ID: 25031463
[TBL] [Abstract][Full Text] [Related]
15. Anaerobic respiration: In vitro efficacy of Nitazoxanide against mitochondriate Acanthamoeba castellanii of the T4 genotype.
Aqeel Y; Siddiqui R; Farooq M; Khan NA
Exp Parasitol; 2015 Oct; 157():170-6. PubMed ID: 26297676
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
Martín-Navarro CM; López-Arencibia A; Arnalich-Montiel F; Valladares B; Piñero JE; Lorenzo-Morales J
Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2111-7. PubMed ID: 23686225
[TBL] [Abstract][Full Text] [Related]
17. Combating the causative agent of amoebic keratitis, Acanthamoeba castellanii, using Padina pavonica alcoholic extract: toxicokinetic and molecular docking approaches.
Abdel-Hakeem SS; Hassan FAM; Hifney AF; Salem SH
Sci Rep; 2024 Jun; 14(1):13610. PubMed ID: 38871751
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.
Mafra CS; Carrijo-Carvalho LC; Chudzinski-Tavassi AM; Taguchi FM; Foronda AS; Carvalho FR; de Freitas D
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6363-72. PubMed ID: 23900604
[TBL] [Abstract][Full Text] [Related]
19. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
Seal D; Hay J; Kirkness C; Morrell A; Booth A; Tullo A; Ridgway A; Armstrong M
Eye (Lond); 1996; 10 ( Pt 4)():413-21. PubMed ID: 8944089
[TBL] [Abstract][Full Text] [Related]
20. Status of the effectiveness of contact lens disinfectants in Malaysia against keratitis-causing pathogens.
Abjani F; Khan NA; Jung SY; Siddiqui R
Exp Parasitol; 2017 Dec; 183():187-193. PubMed ID: 28919333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
